Jaguar Health (JAGX) Notes Payables (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Notes Payables data on file, last reported at $22.1 million in Q1 2026.

• On a quarterly basis, Notes Payables rose 18.46% year-over-year to $22.1 million in Q1 2026; TTM through Mar 2026 was $22.1 million, a 18.46% increase from a year earlier, with the FY2025 full-year figure at $27.4 million, up 127.94% from the prior year.
• Notes Payables for Q1 2026 stood at $22.1 million, down from $27.4 million in the prior quarter.
• Over the last five years, Notes Payables for JAGX reached as high as $27.4 million in Q4 2025 and fell as low as $3.5 million in Q3 2023.
• Historically, Notes Payables has averaged $13.8 million across 5 years, with a median of $12.0 million in 2024.
• Across the five-year window, Notes Payables surged 594.59% in 2022 and slumped 70.1% in 2023, its largest moves.
• Year by year, Notes Payables stood at $15.9 million in 2022, then plunged by 69.36% to $4.9 million in 2023, then jumped by 147.34% to $12.0 million in 2024, then jumped by 127.94% to $27.4 million in 2025, then dropped by 19.54% to $22.1 million in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $22.1 million in Q1 2026, $27.4 million in Q4 2025, and $23.1 million in Q3 2025.